This inventor holds 31 USPTO granted patents and 2 published patent applications and 5 EPO patents, primarily in Pharmaceutical Inhibitors. Top assignees: Eli Lilly and Company, Agouron Pharmaceuticals, Inc.. Active years: 1995-2017.
Location History:
- Indiana, IN (US) (1995)
- Indianapolis, IN (US) (1996 - 2017)
Company Filing History:
Years Active: 1995-2017
Areas of Expertise:
Title: Innovations by Timothy Alan Shepherd: A Pioneer in Pharmaceutical Patents
Introduction
Timothy Alan Shepherd, based in Indianapolis, IN, is a distinguished inventor known for his significant contributions to the pharmaceutical industry. With an impressive portfolio of 31 patents, his work has had a profound impact on drug development, particularly in the treatment of various medical conditions, including cancer and menopause-related symptoms.
Latest Patents
Among Shepherd's most notable recent patents are the 1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, which are valuable as AICARFT inhibitors in cancer treatment. This invention not only encompasses these compounds but also includes formulations and their practical applications in clinical settings. Another significant patent is focused on selective estrogen receptor modulators, aimed at alleviating vasomotor symptoms such as hot flashes, night sweats, and other menopausal challenges faced by women. These advancements highlight Shepherd's commitment to addressing critical health issues through innovative pharmaceutical solutions.
Career Highlights
Throughout his career, Timothy Alan Shepherd has made a name for himself by working with reputable companies such as Eli Lilly and Company and Agouron Pharmaceuticals, Inc. His experience in these esteemed organizations has equipped him with the knowledge and skills necessary to drive innovation in drug discovery and development.
Collaborations
Shepherd's journey in the pharmaceutical sector has been enriched by collaborations with talented professionals. Notably, he has worked alongside esteemed colleagues like William Joseph Hornback and John E Munroe. These partnerships have fostered a collaborative environment that spurs innovation and leads to groundbreaking advancements in pharmaceuticals.
Conclusion
Timothy Alan Shepherd's contributions to the field of pharmaceuticals through his extensive patent portfolio demonstrate his ingenuity and dedication to improving healthcare. His recent inventions are a testament to his innovative spirit, positively impacting the treatment of complex health issues. As he continues to pioneer advancements in pharmaceuticals, his legacy of innovation holds promise for the future of drug development.